199 related articles for article (PubMed ID: 38199607)
21. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
[TBL] [Abstract][Full Text] [Related]
22. Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control.
Zhen Z; Tang W; Wang M; Zhou S; Wang H; Wu Z; Hao Z; Li Z; Liu L; Xie J
Nano Lett; 2017 Feb; 17(2):862-869. PubMed ID: 28027646
[TBL] [Abstract][Full Text] [Related]
23. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
[TBL] [Abstract][Full Text] [Related]
24. Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling.
Tang X; Hou Y; Yang G; Wang X; Tang S; Du YE; Yang L; Yu T; Zhang H; Zhou M; Wen S; Xu L; Liu M
Cell Death Differ; 2016 Jan; 23(1):132-45. PubMed ID: 26068592
[TBL] [Abstract][Full Text] [Related]
25. Tubulointerstitial nephritis antigen-like 1 from cancer-associated fibroblasts contribute to the progression of diffuse-type gastric cancers through the interaction with integrin β1.
Lee D; Ham IH; Oh HJ; Lee DM; Yoon JH; Son SY; Kim TM; Kim JY; Han SU; Hur H
J Transl Med; 2024 Feb; 22(1):154. PubMed ID: 38355577
[TBL] [Abstract][Full Text] [Related]
26. Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
Najafi M; Farhood B; Mortezaee K
J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449
[TBL] [Abstract][Full Text] [Related]
27. Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade.
Jenkins L; Jungwirth U; Avgustinova A; Iravani M; Mills A; Haider S; Harper J; Isacke CM
Cancer Res; 2022 Aug; 82(16):2904-2917. PubMed ID: 35749591
[TBL] [Abstract][Full Text] [Related]
28. Single-cell analysis reveals the COL11A1
Zhang J; Lu S; Lu T; Han D; Zhang K; Gan L; Wu X; Li Y; Zhao X; Li Z; Shen Y; Hu S; Yang F; Wen W; Qin W
Front Pharmacol; 2023; 14():1121586. PubMed ID: 36744260
[No Abstract] [Full Text] [Related]
29. The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases.
Giguelay A; Turtoi E; Khelaf L; Tosato G; Dadi I; Chastel T; Poul MA; Pratlong M; Nicolescu S; Severac D; Adenis A; Sgarbura O; Carrère S; Rouanet P; Quenet F; Ychou M; Pourquier D; Colombo PE; Turtoi A; Colinge J
Theranostics; 2022; 12(17):7624-7639. PubMed ID: 36438498
[No Abstract] [Full Text] [Related]
30. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
31. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
Yu Y; Schuck K; Friess H; Kong B
Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
[TBL] [Abstract][Full Text] [Related]
32. Cancer associated fibroblasts: is the force the path to the dark side?
Barbazán J; Matic Vignjevic D
Curr Opin Cell Biol; 2019 Feb; 56():71-79. PubMed ID: 30308331
[TBL] [Abstract][Full Text] [Related]
33. Discovery of Cell-Surface Vimentin (CSV) as a Sarcoma Target and Development of CSV-Targeted IL12 Immune Therapy.
Batth IS; Li S
Adv Exp Med Biol; 2020; 1257():169-178. PubMed ID: 32483739
[TBL] [Abstract][Full Text] [Related]
34. Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma.
Suzuki J; Aokage K; Neri S; Sakai T; Hashimoto H; Su Y; Yamazaki S; Nakamura H; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Tsuboi M; Ishii G
Lung Cancer; 2021 Mar; 153():1-10. PubMed ID: 33429158
[TBL] [Abstract][Full Text] [Related]
35. Antifibrotic therapy to normalize the tumor microenvironment.
Hauge A; Rofstad EK
J Transl Med; 2020 May; 18(1):207. PubMed ID: 32434573
[TBL] [Abstract][Full Text] [Related]
36. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33.
Ding L; Ren J; Zhang D; Li Y; Huang X; Hu Q; Wang H; Song Y; Ni Y; Hou Y
Carcinogenesis; 2018 Mar; 39(3):397-406. PubMed ID: 29346528
[TBL] [Abstract][Full Text] [Related]
37. Palladin isoforms 3 and 4 regulate cancer-associated fibroblast pro-tumor functions in pancreatic ductal adenocarcinoma.
Alexander JI; Vendramini-Costa DB; Francescone R; Luong T; Franco-Barraza J; Shah N; Gardiner JC; Nicolas E; Raghavan KS; Cukierman E
Sci Rep; 2021 Feb; 11(1):3802. PubMed ID: 33589694
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast Isolation from Mammary Gland Tissue and Syngeneic Murine Breast Cancer Models.
Bartish M; Smith-Voudouris J; Del Rincón SV
Methods Mol Biol; 2023; 2614():171-185. PubMed ID: 36587126
[TBL] [Abstract][Full Text] [Related]
39. Suppression of TGFβ-mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition.
Kim DJ; Dunleavey JM; Xiao L; Ollila DW; Troester MA; Otey CA; Li W; Barker TH; Dudley AC
Br J Cancer; 2018 May; 118(10):1359-1368. PubMed ID: 29695769
[TBL] [Abstract][Full Text] [Related]
40. NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors.
Ford K; Hanley CJ; Mellone M; Szyndralewiez C; Heitz F; Wiesel P; Wood O; Machado M; Lopez MA; Ganesan AP; Wang C; Chakravarthy A; Fenton TR; King EV; Vijayanand P; Ottensmeier CH; Al-Shamkhani A; Savelyeva N; Thomas GJ
Cancer Res; 2020 May; 80(9):1846-1860. PubMed ID: 32122909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
